Invetech

Drawing on decades of experience turning complex healthcare technologies into products for global healthcare companies, we are excited to contribute to the Victorian Medtech Skills and Devices Hub and help strengthen medtech capability. Across several modules, our experts will share what it takes to navigate the path from complex technology development through industrialisation and scale-up to manufacturable solutions ready for global commercialisation. Participants will gain industry perspectives spanning engineering, product development, design for manufacture, quality, scale-up and manufacturing. Supporting the next generation of medtech talent and capability is a priority for us. By sharing the experience and lessons our teams have developed across decades of product development and manufacturing, we hope to help participants build the technical and commercial understanding needed to translate promising technologies into healthcare products with meaningful impact. Learn more about Invetech: https://lnkd.in/dyyKFKj A big thank you to the Victorian Medtech Skills and Device Hub (VMH) for creating an initiative that is strengthening talent and capability across the medtech ecosystem. #Invetech #Medtech #Commercialisation #MedicalTechnology #CareerDevelopment #ProductDevelopment #Manufacturing #VMH

The science behind cell therapies continues to advance at an incredible pace. The next challenge is ensuring manufacturing systems, processes, and infrastructure can keep up.   At Hope Is Not a Workflow, developers, technology providers, and industry experts will come together to share experiences and discuss what's needed to enable the next generation of cell therapy manufacturing.   Paul Tsironis will be presenting Preparing for Scale: Enabling the Future of Cell Therapy Manufacturing Through Automation on Wednesday, August 19th at 10:15 a.m. PT, sharing perspectives on how organizations can use automation and integrated manufacturing solutions to reduce manually intensive workflows and operational bottlenecks today while building the foundation for future scale.   At Invetech, we're passionate about helping innovators overcome complex development and manufacturing challenges so life-changing therapies can reach patients faster.   If you're attending, we would love to connect and continue the conversation. Learn more about our Cell & Gene Therapy Automation solutions: https://lnkd.in/gcMvxP73   #HopeIsNotAWorkflow #CellAndGeneTherapy #AdvancedTherapies #Biomanufacturing #Automation #LifeSciences #Commercialization #PatientImpact #EngineeringInnovation #Invetech #CGT

As we look ahead to Meeting on the Mesa 2026 we're excited to continue the conversations shaping the future of cell and gene therapy. Last year, Invetech President & CEO Andreas Knaack joined the Alliance for Regenerative Medicine to discuss the role of automation in helping scale these therapies while maintaining quality and consistency. As we head into this year's event, the conversation is evolving from how we scale cell and gene therapies to how we manufacture them efficiently, reduce costs, and expand patient access. View the recording here: https://lnkd.in/gWMAZM7k #MeetingOnTheMesa #CellAndGeneTherapy #CGT #Automation #Commercialization #Invetech

We're proud to share that we have been named a finalist in the 2026 Governor of Victoria Export Awards. As a global engineering, product development and manufacturing company, it is an honour to be recognised alongside other outstanding businesses driving innovation and delivering engineering expertise to customers around the world. This recognition reflects the dedication of our incredible team and the trust our clients place in us to solve complex challenges across diagnostics, cell and gene therapy, and life sciences. Congratulations to all finalists. We look forward to celebrating with the Victorian export community in September. Learn more about the awards and finalists: https://lnkd.in/dM63SGVN #GOVEA2026 #GlobalVictoria #ExportAwards #VictorianBusiness #Innovation #Invetech

Quality control (QC) remains one of the biggest constraints in scaling cell and gene therapy manufacturing not only at release, but across the many in-process checkpoints that keep batches moving. As programs scale, QC is where COGS, cycle time, and operational risk increasingly converge. Yet many teams find that even after automating assays, release timelines and costs remain difficult to control.   That challenge was central to our Advanced Therapies Week breakfast session, From Bottleneck to Breakthrough: QC’s Automated Evolution. In this article, Félix A MONTERO-JULIAN PhD, Geoffrey Stephens, PhD, MBA, Michelle Duquette, PhD, Matt Yeung and Kelly Pisarev Lord, Bronze Level CTSM bring together perspectives from pharma, engineering, technology, and AI to unpack what is holding QC back and where progress is realistically possible.   The attached article summarizes the session’s key take aways. We explore where QC bottlenecks are really forming, why isolated automation falls short, and how QC is evolving from a downstream checkpoint into a strategic enabler of informed decision-making and manufacturing scale. Read the full article now: https://lnkd.in/gj3jHK4Y What has been the biggest challenge you’ve faced when scaling QC?   #CellAndGeneTherapy #QualityControl #Biomanufacturing #Automation #Invetech #AdvancedTherapies #ATW2026 #LifeSciences #ManufacturingInnovation #CGT

Invetech's Simon Robinson will be attending the Next Generation Dx Summit in Washington D.C. from 24-26 August. If you're heading along, connect with Simon to discuss diagnostics innovation, product development, and bringing new technologies to market. Whether you're exploring a new diagnostic technology, tackling development challenges, or preparing for scale-up, Simon would love to chat. Want to connect before the event? Reach out to Simon at simon.robinson@invetech.us Discover how Invetech partners with diagnostics innovators to bring products to market: https://lnkd.in/gv7NG4ME #Diagnostics #NextGenerationDx #MedTech #ProductDevelopment #Invetech #Engineering

Thank you, ADLM 2026, for another outstanding event and for bringing together innovators, partners, and industry leaders from across the diagnostics community. Our Ensemble™ platform took center stage, demonstrating how proven core technologies can help diagnostic developers move faster from concept to commercialization while maintaining flexibility and control. A powerful example is General Fluidics’ Axess™ platform. By leveraging Ensemble, the team was able to accelerate development of this differentiated point-of-care diagnostic solution and create a faster path toward broader access. We were delighted to have the General Fluidics team join us at the Invetech booth, giving attendees the opportunity to experience Axess firsthand and learn more about its development journey. "The pace of innovation in diagnostics continues to accelerate. We are proud to work alongside our customers and partners to help transform promising ideas into robust products that can make a meaningful difference in healthcare." – Andreas Knaack, CEO, Invetech Interested in learning more about how Invetech helps bring diagnostic and life science innovations to market? Visit our website to explore our capabilities, technologies, and success stories: https://lnkd.in/dyyKFKj   #ADLM2026 #Diagnostics #PointOfCare #POCT #IVD #HealthcareInnovation #GeneralFluidics #LifeSciences #MedTech #Invetech GENERAL FLUIDICS CORPORATION

We're excited to be sharing our latest research at ADLM 2026 with our poster, "Integration of a Rapid Real-time PCR Module into Point-of-Care Instruments."   A big thank you to Damian Verdnik for authoring and presenting this work on behalf of the Invetech team (Stuart Knowles, Tim Lee & Scott Thompson) and highlighting how innovative PCR technology can help accelerate molecular testing at the point of care.    The poster showcases Invetech's approach to integrating compact, high-performance PCR capabilities into point-of-care instruments, enabling faster results while maintaining strong analytical performance.    "I really enjoyed the passion and energy while presenting during the POC poster session at ADLM" Damian Verdnik, VP, Diagnostics.   If you're attending ADLM, we'd love to connect. Stop by Booth #2969 to learn more about Invetech's diagnostic and point-of-care technology capabilities. Interested in learning more? Explore the poster and our diagnostic capabilities on our website: https://lnkd.in/g-kc_cNX   #ADLM2026 #Diagnostics #PCR #PointOfCare #MolecularDiagnostics #MedTech #Invetech #ProductDevelopment

Do you have an assay that you are keen to move to a product fast and without starting from scratch? We have a platform of proven core technologies configurable around your workflow. • Proven foundations - tested configurations you can rely on • Faster development - reusable modules across Point of Care (POC) and benchtop systems • Full flexibility - design the system your way, without being locked in Whether you’re developing for point of care or benchtop, with our Ensemble platform, we can help you reduce risk, move faster, and stay in control of your product. See how Invetech's Ensemble works: https://lnkd.in/gRspspy4 If you are attending ADLM, come and see it in action at Booth 2969. #ADLM2026 #DiagnosticsInnovation #PointOfCare #MedTech  #Invetech #productdevelopment

Strong partnerships rely on trust, transparency, and the ability to have honest conversations about risk. In our work with General Fluidics, transparency has played a key role in helping both teams solve complex challenges together. It’s this kind of open, collaborative approach that helps bring ambitious diagnostic technologies closer to the people who need them. Watch the video: https://lnkd.in/gb9vNKGF Read More: https://lnkd.in/gcAhrqXb Visit Booth #2969 at ADLM 2026 to connect with Invetech and General Fluidics. GENERAL FLUIDICS CORPORATION Robert Granier #Diagnostics #PointOfCareTesting #MedicalTechnology #ProductDevelopment #Collaboration #Innovation